Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
Julie Ryan WolfCharles E HecklerJoseph J GuidoAnita R PeoplesJennifer S GewandterMarilyn LingVincent P VinciguerraThomas AndersonLisa EvansJames WadeAlice P PentlandGary R MorrowPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2017)
Oral curcumin did not significantly reduce radiation dermatitis severity compared to placebo. The skin rating variation and broad eligibility criteria could not account for the undetectable therapeutic effect. An objective measure for radiation dermatitis severity and further exploration for an effective treatment for radiation dermatitis is warranted.